|
WO2017182580A1
|
|
Methods for the diagnosis and the treatment of reproduction-related disorders and methods for contraception
|
|
WO2017089347A1
|
|
Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
|
|
US2016317443A1
|
|
HDL comprising a therapeutic agent and use in therapy
|
|
FR3038507A1
|
|
INSERTION TUBE FOR A SOFT BRONCHOSCOPE
|
|
US2017313758A1
|
|
Polypeptides for the Treatment of Angiogenesis or Lymphangiogenesis-Related Diseases
|
|
CA2961597A1
|
|
Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the il-20r.
|
|
CA2966536A1
|
|
Method and apparatus for ultrasound imaging of brain activity
|
|
US2017209488A1
|
|
Methods for treating neuromuscular junction-related diseases
|
|
CA2954562A1
|
|
Methods for diagnosing hematological cancers
|
|
CA2949883A1
|
|
Methods for predicting the survival time of patients suffering from cancer
|
|
CA2932495A1
|
|
Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject
|
|
FR3028742A1
|
|
VIBROTACTILE STIMULATION DEVICE
|
|
FR3028745A1
|
|
VIBROTACTILE STIMULATION DEVICE
|
|
US2016222390A1
|
|
Methods and pharmaceutical compositions for treatment of cystic fibrosis
|
|
US2016136183A1
|
|
Pharmaceutical compositions for preventing glucocorticoid-induced skin thinning
|
|
US2016068808A1
|
|
Methods for stimulating antigen-specific T cell responses
|
|
CA2929386A1
|
|
Neuregulin allosteric anti-her3 antibody
|
|
US2015247855A1
|
|
Method for the treatment of cardiovascular fibrosis
|
|
US2015239978A1
|
|
Antibodies directed against ICOS for treating graft-versus-host disease
|
|
US2015072932A1
|
|
Modified apelin polypeptides
|
